Molecular Matrix, a privately held company that arose from the University of California, Davis, received FDA approval for its Osteo-P bone graft substitute technology. Osteo-P is a non-mineralized, ...
Please provide your email address to receive an email when new articles are posted on . Postmenopausal women assigned denosumab have increases in mineral to matrix ratio at the cortical and cancellous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results